Global Gene Synthesis Market Size By Type (Below 1000 bp, 1001-3000 bp), By Application (Commercial, Academic Research), By Region, And Segment Forecasts, 2023 to 2032

lobal Gene Synthesis Market Report Description

The Global Gene Synthesis Market was valued at USD 3.9 billion in 2023 and is projected to reach USD 10.4 billion by 2031, registering a CAGR of 12.8% during the forecast period (2023–2031). The market is witnessing significant growth driven by the increasing demand for synthetic genes in drug discovery, vaccine development, genetic engineering, and synthetic biology research. Advancements in DNA synthesis technologies, coupled with reduced costs of gene sequencing and synthesis, are fueling the widespread adoption of gene synthesis across biotechnology, pharmaceutical, and academic research institutions.

Gene synthesis is playing a critical role in enabling precision medicine, personalized therapeutics, and the rapid development of mRNA vaccines, which gained significant momentum post the COVID-19 pandemic. Additionally, the expansion of synthetic biology applications in agriculture, industrial enzymes, and biofuels further accelerates market growth.

Drivers

Advancements in Synthetic Biology

Rapid progress in synthetic biology is creating high demand for custom-designed genes for various applications, including metabolic engineering, protein production, and novel therapeutics.

Growing Demand for Personalized Medicine

The shift towards precision and personalized medicine is driving the need for synthetic genes for targeted therapies, diagnostic assays, and gene therapy.

Decreasing Costs of DNA Synthesis

The cost of gene synthesis has significantly reduced due to advancements in automation and error-correction techniques, making synthetic genes more accessible to researchers and commercial entities.

Increased Investments in Genomic Research

Government and private sector investments in genomics, coupled with expanding CRISPR and gene-editing research, are boosting the need for synthetic DNA.

Restraints

Ethical and Regulatory Concerns

Ethical debates and strict regulations surrounding genetic modification and synthetic biology can limit the pace of commercialization.

Technical Limitations in Long Gene Synthesis

Challenges in synthesizing large DNA sequences with high accuracy remain a barrier for certain high-complexity applications.

Data Privacy and Biosecurity Issues

Concerns regarding bioterrorism and misuse of synthetic genes pose security risks, leading to stricter control measures.

Opportunities

Expansion in mRNA Vaccine and Therapeutics Development

Post-pandemic, the demand for mRNA-based vaccines and therapeutics has surged, opening vast opportunities for gene synthesis providers.

Agricultural Biotechnology Applications

Gene synthesis enables the development of genetically engineered crops with improved yield, pest resistance, and nutritional value, creating new growth avenues.

Emergence of AI and Automation in Gene Design

Integrating AI for gene sequence optimization and automated synthesis platforms will significantly reduce turnaround times and expand market reach.

Market by System Type Insights

Oligonucleotide Synthesis Services accounted for the largest market share in 2023, driven by their use in PCR, sequencing, and gene editing applications.

Custom Gene Synthesis Services are expected to grow at the highest CAGR due to increasing research in drug development and functional genomics.

Market by End-use Insights

Pharmaceutical & Biotechnology Companies held over 40% market share in 2023, leveraging synthetic genes for therapeutic development and vaccine manufacturing.

Academic & Research Institutions are also a key segment, driven by increasing funding for genomics and synthetic biology research.

Market by Regional Insights

North America dominated the market in 2023, supported by advanced genomic research infrastructure, strong biotech industry presence, and favorable government funding.

Asia-Pacific is projected to witness the highest growth rate during 2023–2031, fueled by increasing investments in life sciences research in countries like China, India, and Japan.

Europe remains a significant market due to the high adoption of synthetic biology in industrial and healthcare applications.

Competitive Scenario

Key players in the Global Gene Synthesis Market include Thermo Fisher Scientific, GenScript Biotech, Integrated DNA Technologies (IDT), Twist Bioscience, Eurofins Genomics, DNA2.0 (ATUM), OriGene Technologies, Biomatik, Genewiz (Azenta Life Sciences), and Bio Basic Inc.

Leading players are focusing on automation, error-free synthesis technologies, and strategic collaborations to expand their global reach.

2023: Twist Bioscience launched an advanced high-throughput DNA synthesis platform to reduce turnaround times for large-scale projects.

2024: GenScript partnered with a leading mRNA vaccine developer to supply large-scale synthetic genes for vaccine pipelines.

2025: IDT introduced an AI-driven gene optimization tool integrated with its synthesis services.

Scope of Work – Global Gene Synthesis Market

Key Market Developments

2023: Twist Bioscience expanded its synthetic gene production capacity in the U.S. to meet growing demand in drug discovery and vaccine development.

2024: Eurofins Genomics launched a next-gen high-fidelity DNA synthesis platform with error correction technology for long DNA sequences.

2025: Genewiz (Azenta) established a new R&D facility in Singapore to strengthen its presence in the Asia-Pacific market.

FAQs

What is the current market size of the Global Gene Synthesis Market?

The market size was valued at USD 3.9 billion in 2023.

What is the major growth driver of the Global Gene Synthesis Market?

The market is primarily driven by advancements in synthetic biology, increasing demand for precision medicine, and the growing adoption of mRNA-based therapeutics.

Which region is expected to dominate the market during the forecast period?

North America is expected to remain the leading region, while Asia-Pacific will record the highest growth rate.

Which segment accounted for the largest market share in the Gene Synthesis Market?

Oligonucleotide synthesis services accounted for the largest share in 2023.

Who are the key market players in the Global Gene Synthesis Market?

Major players include Thermo Fisher Scientific, GenScript, Twist Bioscience, IDT, and Eurofins Genomics.

Would you like me to also create a visual one-page infographic summary of this report for better presentation?